ES2423730T3 - Uso de una composición sinérgica como agente terapéutico o agente de desinfección - Google Patents

Uso de una composición sinérgica como agente terapéutico o agente de desinfección Download PDF

Info

Publication number
ES2423730T3
ES2423730T3 ES08773742T ES08773742T ES2423730T3 ES 2423730 T3 ES2423730 T3 ES 2423730T3 ES 08773742 T ES08773742 T ES 08773742T ES 08773742 T ES08773742 T ES 08773742T ES 2423730 T3 ES2423730 T3 ES 2423730T3
Authority
ES
Spain
Prior art keywords
composition
amounts
weight
wound
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08773742T
Other languages
English (en)
Spanish (es)
Inventor
Barbara Krug
Sven Eggerstedt
Richard Bloss
Christiane Ostermeyer
Thomas Lisowsky
Karlheinz Esser
Frank Bürger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Multibind Biotec GmbH
Bode Chemie GmbH and Co KG
Original Assignee
Multibind Biotec GmbH
Bode Chemie GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multibind Biotec GmbH, Bode Chemie GmbH and Co KG filed Critical Multibind Biotec GmbH
Application granted granted Critical
Publication of ES2423730T3 publication Critical patent/ES2423730T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
ES08773742T 2007-06-28 2008-06-27 Uso de una composición sinérgica como agente terapéutico o agente de desinfección Active ES2423730T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007030103A DE102007030103A1 (de) 2007-06-28 2007-06-28 Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
DE102007030103 2007-06-28
PCT/EP2008/005292 WO2009000551A1 (de) 2007-06-28 2008-06-27 Verwendung einer synergistischen zusammensetzung als therapeutisches mittel oder desinfektionsmittel

Publications (1)

Publication Number Publication Date
ES2423730T3 true ES2423730T3 (es) 2013-09-24

Family

ID=39817047

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08773742T Active ES2423730T3 (es) 2007-06-28 2008-06-27 Uso de una composición sinérgica como agente terapéutico o agente de desinfección

Country Status (7)

Country Link
US (1) US8557265B2 (enExample)
EP (2) EP2489370A1 (enExample)
JP (1) JP2010531320A (enExample)
CA (1) CA2692341A1 (enExample)
DE (1) DE102007030103A1 (enExample)
ES (1) ES2423730T3 (enExample)
WO (1) WO2009000551A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005020327A1 (de) * 2005-04-30 2006-11-09 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen
DE102008064481A1 (de) 2008-12-18 2010-08-12 Bode Chemie Gmbh Kombinierte Desinfektions- und Dekontaminationsmittel mit erhöhter Wirksamkeit
EP2481288A1 (en) 2011-01-26 2012-08-01 multiBIND biotec GmbH Synergistic disinfecting compositions with essential oils
DE102015113641A1 (de) 2015-08-18 2017-02-23 Bode Chemie Gmbh Desinfektionsmittel mit organischen Säuren
US20190000876A1 (en) * 2015-09-29 2019-01-03 Tecuro Ag Stabilized antiseptic preparations
EP3654944B1 (en) * 2017-07-20 2025-11-26 Nanotess Inc. Formulation comprising nanostructured, biocompatible and biocatalytic material for the treatment of wounds and infections
MX2018002983A (es) * 2018-03-09 2019-09-10 Inst Tecnologico Jose Mario Molina Pasquel Y Henriquez Suspensión antiviral potencializadora para tratamiento de fibras y su metodo de preparación.
DE102024109695B3 (de) 2024-04-08 2025-03-06 Allvater Biosolutions GmbH Wasserlösliches Dekontaminationskonzentrat, Dekontaminationslösung, Herstellungsverfahren zur Herstellung einer Dekontaminationslösung sowie Bereitstellungsvefahren zur Bereitstellung eines Dekontaminationskonzentrats

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7007A (en) * 1850-01-08 Improvement in machinery for making cotton cordage
US3018A (en) * 1843-03-21 Coupling for qttilting-frames
FR2041M (fr) * 1962-04-17 1963-09-30 Andre Anselme Marie Composition thérapeutique a propriétés cytotoxiques a base d'acide ascorbique et d'ions métalliques.
EP0046409A1 (en) * 1980-08-20 1982-02-24 Erwin Günther Walliczek A process for the preparation of a solution of a cuprous complex; solutions of the cuprous complexes for use in the therapeutic treatment of the human or animal body; and a method of therapeutic treatment of a plant
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5928958A (en) * 1994-07-27 1999-07-27 Pilgrimm; Herbert Superparamagnetic particles, process for their manufacture and usage
GB2292746A (en) * 1994-08-30 1996-03-06 John Peter Hugh Williamson Bleach compositions
ATE262799T1 (de) * 1996-01-31 2004-04-15 Univ South Alabama Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
DE19603653B4 (de) 1996-02-01 2004-02-12 Siemens Ag Sendestufe, insbesondere für ein fernbedienbares Diebstahlschutzsystem eines Kraftfahrzeugs
JP3853985B2 (ja) * 1998-08-03 2006-12-06 有限会社 健康百二十才 鉄イオン含有殺菌液
MXPA01003507A (es) * 1998-10-08 2002-06-26 Hampar L Karagoezian Antimicrobiano sinergico, preparaciones dermatologicas y oftalmicas que contienen clorito y peroxido de hidrogeno.
EP1154804B1 (en) * 1999-02-26 2008-02-20 Johnson & Johnson Consumer Companies, Inc. Bioadhesive antibacterial wound healing composition
ES2232590T3 (es) * 2000-01-28 2005-06-01 Merck Patent Gmbh Frmulacion que contiene derivados de benzofuranona para la proteccion contra el stress por oxidacion.
JP2002104974A (ja) * 2000-09-29 2002-04-10 Nichiban Co Ltd ハイドロゲル損傷皮膚治療剤
DE60031726T2 (de) 2000-09-29 2007-09-06 The Procter & Gamble Company, Cincinnati Zusammensetzungen zum neutralisieren von allergenen
US20030185915A1 (en) * 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
GB0212405D0 (en) * 2002-05-29 2002-07-10 Insignion Holdings Ltd Composition and its therapeutic use
JP4677192B2 (ja) * 2004-02-20 2011-04-27 株式会社オゾテック オゾン溶存グリセリン溶液の製造方法
US7115287B2 (en) 2005-03-03 2006-10-03 F.L.M., L.L.C. Topical medicament and method of use
DE102005020327A1 (de) * 2005-04-30 2006-11-09 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen
DE102005044361A1 (de) * 2005-09-09 2007-03-15 Aesculap Ag & Co. Kg Antimikrobielles medizintechnisches Produkt, Verfahren zu seiner Herstellung und Verwendung
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
DE102006018983A1 (de) * 2006-04-25 2007-10-31 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur effizienten Degradation und Inaktivierung von Proteinen und Nukleinsäuren bei erhöhten Temperaturen
DE102006049108B4 (de) * 2006-10-13 2019-05-02 Agxx Intellectual Property Holding Gmbh Bioaktive, rutheniumhaltige Beschichtungen, deren Verwendung und Verfahren zur Beschichtung einer Vorrichtung

Also Published As

Publication number Publication date
JP2010531320A (ja) 2010-09-24
CA2692341A1 (en) 2008-12-31
WO2009000551A1 (de) 2008-12-31
WO2009000551A8 (de) 2009-07-23
US20100119566A1 (en) 2010-05-13
EP2489370A1 (de) 2012-08-22
EP2170398A1 (de) 2010-04-07
US8557265B2 (en) 2013-10-15
DE102007030103A1 (de) 2009-01-02
EP2170398B1 (de) 2013-05-15

Similar Documents

Publication Publication Date Title
US12128120B2 (en) Wound cleansing method
Percival et al. Antiseptics for treating infected wounds: efficacy on biofilms and effect of pH
US8557265B2 (en) Use of a synergistic composition as a therapeutic agent of disinfectant
AU2014253977B2 (en) Antimicrobial compositions of aminoglycosidic antibiotics and zinc ion chelators
CN101491245B (zh) 一种含林蛙抗菌肽的消毒制剂及其制备方法和应用
Roberts Antimicrobial agents used in wound care
US20240148932A1 (en) Wound dressing with preventive biofilm additive
Vachhrajani et al. Antiseptics and Local Antibiotics
ES2784275B2 (es) Antiséptico de acción prolongada para el lavado higiénico por fricción y lavado pre-quirúrgico de manos
TWI687229B (zh) 具有協同作用之生醫材料及其製造方法